Cellular Oncology

Papers
(The TQCC of Cellular Oncology is 14. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Deciphering the molecular landscape: evolutionary progression from gynecomastia to aggressive male breast cancer101
Dissecting the single-cell transcriptome network of macrophage and identifies a signature to predict prognosis in lung adenocarcinoma80
Application of circulating tumour cells to predict response to treatment in head and neck cancer74
Publisher Correction to: RAB37 suppresses the EMT, migration and invasion of gastric cancer cells by mediating autophagic degradation of β-catenin73
HNRNPH1 stabilizes FLOT2 mRNA in a non-canonical m6A-dependent manner to promote malignant progression in nasopharyngeal carcinoma58
Pathways and outputs orchestrated in tumor microenvironment cells by hypoxia-induced tumor-derived exosomes in pan-cancer58
Methionine-producing tumor micro(be) environment fuels growth of solid tumors57
The therapeutic potential of exosomes in lung cancer52
CoQ10 reduces glioblastoma growth and infiltration through proteome remodeling and inhibition of angiogenesis and inflammation51
Asymmetric post-translational modifications regulate the nuclear translocation of STAT3 homodimers in response to leukemia inhibitory factor51
Molecular mechanisms underlying the action of carcinogens in gastric cancer with a glimpse into targeted therapy46
RETRACTED ARTICLE: The autocrine glycosylated-GREM1 interacts with TGFB1 to suppress TGFβ/BMP/SMAD-mediated EMT partially by inhibiting MYL9 transactivation in urinary carcinoma42
Proteomic characterisation of prostate cancer intercellular communication reveals cell type-selective signalling and TMSB4X-dependent fibroblast reprogramming42
Exploring the impact of PDGFD in osteosarcoma metastasis through single-cell sequencing analysis40
Ubiquilin-4 induces immune escape in gastric cancer by activating the notch signaling pathway39
Targeting nucleolin improves sensitivity to chemotherapy in acute lymphoblastic leukemia38
TRPV4 drives the progression of leiomyosarcoma by promoting ECM1 generation and co-activating the FAK/PI3K/AKT/GSK3β pathway36
SUMOylation inhibitors activate anti-tumor immunity by reshaping the immune microenvironment in a preclinical model of hepatocellular carcinoma35
FSCN1 induced PTPRF-dependent tumor microenvironment inflammatory reprogramming promotes lung adenocarcinoma progression via regulating macrophagic glycolysis34
Trends in immunotherapy for oral squamous cell carcinoma32
In vivo study revealed pro-tumorigenic effect of CMTM3 in hepatocellular carcinoma involving the regulation of peroxisome proliferator-activated receptor gamma (PPARγ)31
RAB37 suppresses the EMT, migration and invasion of gastric cancer cells by mediating autophagic degradation of β-catenin30
Loss of histone deubiquitinase Bap1 triggers anti-tumor immunity28
High-plex spatial transcriptomic profiling reveals distinct immune components and the HLA class I/DNMT3A/CD8 modulatory axis in mismatch repair-deficient endometrial cancer28
Neuregulin-induced HER3 activation drives migration in head and neck squamous cell carcinoma via HER2 and FAK signaling pathways27
Dual anti-angiogenic and anti-metastatic activity of myriocin synergistically enhances the anti-tumor activity of cisplatin27
Next-generation BCMA-targeted chimeric antigen receptor CARTemis-1: the impact of manufacturing procedure on CAR T-cell features27
OSW-1 induces apoptosis and cyto-protective autophagy, and synergizes with chemotherapy on triple negative breast cancer metastasis27
Neuropilin-2 acts a critical determinant for epithelial-to-mesenchymal transition and aggressive behaviors of human head and neck cancer27
Silencing AHNAK promotes nasopharyngeal carcinoma progression by upregulating the ANXA2 protein26
Dipyridamole enhances the anti-cancer ability of aspirin against colorectal cancer by inducing apoptosis in an unfolded protein response-dependent manner26
RRM2 as a novel prognostic and therapeutic target of NF1-associated MPNST26
From basic research to clinical application: targeting fibroblast activation protein for cancer diagnosis and treatment25
Ezrin accelerates breast cancer liver metastasis through promoting furin-like convertase-mediated cleavage of Notch124
TRIM28 promotes tumor growth and metastasis in breast cancer by targeting the BRD7 protein for ubiquitination and degradation24
Correction to: 3D bioprinted tumor model: a prompt and convenient platform for overcoming immunotherapy resistance by recapitulating the tumor microenvironment24
Aberrant expression of circular RNA DHPR facilitates tumor growth and metastasis by regulating the RASGEF1B/RAS/MAPK axis in hepatocellular carcinoma23
Modulation of miR-146b by N6-methyladenosine modification remodels tumor-associated macrophages and enhances anti-PD-1 therapy in colorectal cancer23
The survival prediction analysis and preliminary study of the biological function of YEATS2 in hepatocellular carcinoma23
Exosomes: a potential diagnostic and treatment modality in the quest for counteracting cancer23
USP28 promotes tumor progression and glycolysis by stabilizing PKM2/Hif1-α in cholangiocarcinoma22
Feature-weight based measurement of cancerous transcriptome using cohort-wide and sample-specific information22
OrganoIDNet: a deep learning tool for identification of therapeutic effects in PDAC organoid-PBMC co-cultures from time-resolved imaging data22
TBX21 attenuates colorectal cancer progression via an ARHGAP29/RSK/GSK3β dependent manner22
Emerging roles of deubiquitinating enzymes in actin cytoskeleton and tumor metastasis22
Small extracellular vesicles promote invadopodia activity in glioblastoma cells in a therapy-dependent manner21
Cancer/testis-45A1 promotes cervical cancer cell tumorigenesis and drug resistance by activating oncogenic SRC and downstream signaling pathways21
Osteopontin secreted from obese adipocytes enhances angiogenesis and promotes progression of pancreatic ductal adenocarcinoma in obesity21
Targeting MEK/COX-2 axis improve immunotherapy efficacy in dMMR colorectal cancer with PIK3CA overexpression21
Extracellular vesicles related gene HSPH1 exerts anti-tumor effects in prostate cancer via promoting the stress response of CD8 + T cells21
Prognostic significance of collagen signatures at breast tumor boundary obtained by combining multiphoton imaging and imaging analysis21
Integrated analysis of single-cell RNA-seq and bulk RNA-seq reveals immune suppression subtypes and establishes a novel signature for determining the prognosis in lung adenocarcinoma20
The composition and roles of gastric stem cells in epithelial homeostasis, regeneration, and tumorigenesis20
The PPP2R1A cancer hotspot mutant p.R183W increases clofarabine resistance in uterine serous carcinoma cells by a gain-of-function mechanism20
Targeting CSPG4 enhances the anti-tumor activity of CAR-NK cells for glioblastoma20
Iron metabolism in colorectal cancer: a balancing act20
Lenalidomide overcomes the resistance to third-generation CD19-CAR-T cell therapy in preclinical models of diffuse large B-cell lymphoma19
Cancer-associated fibroblast-derived extracellular vesicles facilitate metastasis in hepatocellular carcinoma by delivering CTGF19
Lactylation: the regulatory code of cellular life activity and a barometer of diseases19
Retraction Note: TRAIL enhances quinacrine-mediated apoptosis in breast cancer cells through induction of autophagy via modulation of p21 and DR5 interactions19
Non-coding RNA regulation of integrins and their potential as therapeutic targets in cancer19
Targeting the Notch-Furin axis with 2-hydroxyoleic acid: a key mechanism in glioblastoma therapy19
PAQR5 inhibits the growth and metastasis of clear cell renal cell carcinoma by suppressing the JAK/STAT3 signaling pathway19
Integrating multi-modal transcriptomics identifies cellular subtypes with distinct roles in PDAC progression18
Vimentin promotes glioma progression and maintains glioma cell resistance to oxidative phosphorylation inhibition18
Distinct tumor microenvironment landscapes of rectal cancer for prognosis and prediction of immunotherapy response18
HBO1 determines epithelial-mesenchymal transition and promotes immunotherapy resistance in ovarian cancer cells18
HDAC6: A unique HDAC family member as a cancer target18
GDF15 induces chemoresistance to oxaliplatin by forming a reciprocal feedback loop with Nrf2 to maintain redox homeostasis in colorectal cancer18
Non-glycanated ΔDCN isoform in muscle invasive bladder cancer mediates cancer stemness and gemcitabine resistance18
Role of ELMO1 in inflammation and cancer—clinical implications18
Nilotinib in combination with sunitinib renders MCL-1 for degradation and activates autophagy that overcomes sunitinib resistance in renal cell carcinoma18
circRNA_0067717 promotes paclitaxel resistance in nasopharyngeal carcinoma by acting as a scaffold for TRIM41 and p5317
Low-dose SAHA enhances CD8+ T cell-mediated antitumor immunity by boosting MHC I expression in non-small cell lung cancer17
RACK1 attenuates pancreatic tumorigenesis by suppressing acinar-to-ductal metaplasia through inflammatory signaling modulation17
DNA-methylome-derived epigenetic fingerprint as an immunophenotype indicator of durable clinical immunotherapeutic benefits in head and neck squamous cell carcinoma17
Tumour-derived exosomal lncRNA SNHG16 induces telocytes to promote metastasis of hepatocellular carcinoma via the miR-942-3p/MMP9 axis17
HVEM in acute lymphocytic leukemia facilitates tumour immune escape by inhibiting CD8+ T cell function17
E3 ubiquitin ligases in cancer stem cells: key regulators of cancer hallmarks and novel therapeutic opportunities17
Marine derived macrolide bryostatin 4 inhibits the TGF-β signaling pathway against acute erythroleukemia17
Tumor-infiltrating myeloid cells; mechanisms, functional significance, and targeting in cancer therapy16
Therapeutic exosomes loaded with SERPINA5 attenuated endometrial cancer cell migration via the integrin β1/FAK signaling pathway16
Targeting TRIM24 promotes neuroblastoma differentiation and decreases tumorigenicity via LSD1/CoREST complex16
Plasma cell signatures predict prognosis and treatment efficacy for lung adenocarcinoma16
Mapping the immune terrain in lung adenocarcinoma progression: Tfh-like cells in tertiary lymphoid structures16
Trained immunity alleviates the progression of melanoma during sepsis-associated immunoparalysis16
Characterization and proteomic analysis of plasma-derived small extracellular vesicles in locally advanced rectal cancer patients16
Microbial metabolite trimethylamine-N-oxide induces intestinal carcinogenesis through inhibiting farnesoid X receptor signaling16
Cell death in glioblastoma and the central nervous system16
Host-derived growth factors drive ERK phosphorylation and MCL1 expression to promote osteosarcoma cell survival during metastatic lung colonization15
Targeting human mitochondrial NAD(P)+-dependent malic enzyme (ME2) impairs energy metabolism and redox state and exhibits antileukemic activity in acute myeloid leukemia15
Antitumor activity of afatinib in EGFR T790M-negative human oral cancer therapeutically targets mTOR/Mcl-1 signaling axis15
Publisher Correction to: RETRACTED ARTICLE: Human bone marrow-derived mesenchymal stem cell-secreted exosomes overexpressing microRNA-34a ameliorate glioblastoma development via down-regulating MYCN15
DNASE1L3 inhibits hepatocellular carcinoma by delaying cell cycle progression through CDK215
LncRNA MIR4435-2HG drives cancer progression by modulating cell cycle regulators and mTOR signaling in stroma-enriched subtypes of urothelial carcinoma of the bladder15
Lactate score classification of hepatocellular carcinoma helps identify patients with tumors that respond to immune checkpoint blockade therapy15
AKT inhibition sensitizes EVI1 expressing colon cancer cells to irinotecan therapy by regulating the Akt/mTOR axis15
Identification of a novel gene signature related to prognosis and metastasis in gastric cancer15
Integrating bulk and single-cell transcriptomics to elucidate the role and potential mechanisms of autophagy in aging tissue15
Stiffened tumor microenvironment enhances perineural invasion in breast cancer via integrin signaling14
Allelic expression imbalance of CDKN2A variants in childhood acute lymphoblastic leukemia14
The m1A-SFRP2-NFAT/TOX axis governs T cell exhaustion in gastric cancer14
RCN2 promotes Nasopharyngeal carcinoma progression by curbing Calcium flow and Mitochondrial apoptosis14
ADAR1 enhances tumor proliferation and radioresistance in non-small cell lung cancer by interacting with Rad1814
VE-822 upregulates the deubiquitinase OTUD1 to stabilize FHL1 to inhibit the progression of lung adenocarcinoma14
Spatiotemporal modulation of SMAD4 by HBx is required for cellular proliferation in hepatitis B-related liver cancer14
ABCA6 affects the malignancy of Ewing sarcoma cells via cholesterol-guided inhibition of the IGF1R/AKT/MDM2 axis14
Integrative proteomics and n-glycoproteomics reveal the synergistic anti-tumor effects of aspirin- and gemcitabine-based chemotherapy on pancreatic cancer cells14
Triggering immunogenic death of cancer cells by nanoparticles overcomes immunotherapy resistance14
0.2174289226532